News Opinion Editor's Corner COVID-19 and the Heart: Insights From the Front Lines Shelley Wood March 12, 2020
News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020
News Conference News ISC 2020 Telehealth Program Helps Minority Stroke Survivors Control BP Todd Neale February 26, 2020
News Daily News Impella Redux: JAMA Publication Post-AHA Renews Push for More Data Caitlin E. Cox February 14, 2020
News Daily News ACC Releases Initial Cardiac Guidance on Novel Coronavirus Todd Neale February 13, 2020
News Daily News Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation Todd Neale February 04, 2020
News Daily News ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study Yael L. Maxwell January 16, 2020
News Daily News EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up Michael O'Riordan December 10, 2019
News Features Subtherapeutic Heparin: As Stories Multiply, Concerns Mount Yael L. Maxwell November 27, 2019
News Conference News AHA 2019 Early Data Favorable for New RNAi Therapies to Reduce Triglycerides Caitlin E. Cox November 19, 2019
News Daily News Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms Caitlin E. Cox November 15, 2019
News Conference News VIVA 2019 Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee? L.A. McKeown November 06, 2019
News Daily News For Percutaneous LVADs, Vascular Complications Decreasing but Still Common Caitlin E. Cox November 06, 2019
News Conference News TCT 2019 Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA Todd Neale October 04, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Daily News CMS Proposes Cuts to Cardiac CT Reimbursement, Provoking SCCT Ire Yael L. Maxwell August 26, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019